Overall verdict
Neutral
5.5/10
1-year performance
-9.72%
Score breakdown
Down 9.7% over 1 year, 46% of the 52-week range.
Strongest: Financial strength 10.0/10. Weakest: Profitability 3.6/10.
AdvancedAdvT Limited engages in the provision of software solutions and platforms in Europe, the United Kingdom, North America, and internationally. It offers business solutions and healthcare compliance; and human capital management. The company also operates financial management software, healthcare intelligence compliance and accreditation software, AI based healthcare intelligence compliance and accreditation software, intelligent process automation software, low code digital platform, resource planning and talent management software, workforce management software, and cloud-based workforce management SaaS products.
The company was formerly known as Marwyn Acquisition Company I Limited and changed its name to AdvancedAdvT Limited in March 2021. AdvancedAdvT Limited was incorporated in 2020 and is headquartered in London, the United Kingdom.
Sector
Information Technology
Industry
Software
Primary listing
Lse
United Kingdom
CEO
Vinodka Murria
Founded
2020
Employees
370
Revenue / employee
154 283 GBP
Next earnings
February 1, 2027 (estimated)
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
1.90 GBP
52-week low
1.39 GBP
1-year performance
-9.72%
Declining
Year-to-date performance
-5.80%
Declining
Drawdown
-14.47%
Mild pullback
Position in the 52-week range
46% of range
Range: 1.49 GBP - 1.66 GBP (2 methods agree)
Gross margin 58.1%, net margin 17.0%, ROIC 6.5%, ROE 6.5%.
Net margin
17.05%
High
Sector -2.68%|S&P 13.35%
Gross margin
58.12%
Exceptional
Return on equity (ROE)
6.46%
Low
Sector -1.29%|S&P 16.98%
Return on invested capital (ROIC)
6.45%
Low
Free cash flow margin (FCF)
19.88%
High
Profit-to-cash conversion (FCF conversion)
1.17x
High
Revenue to net income
Growth
5.0/10Revenue up 13.2% over 1 year.
Revenue (trailing 12 months)
57.1M GBP
Revenue growth (1y)
13.20%
Hyper-growth
Revenue growth (3y)
—
EPS growth (1y)
-58.13%
Declining
EPS CAGR (5y)
—
EPS revisions (3 months)
—
Valuation
5.2/10P/E 24.1x, forward P/E 22.0x, EV/EBITDA 7.0x, PEG 0.46. The multiple sits in the 77th percentile of its own 5-year history.
P/E (TTM)
24.1x
Expensive
Sector 14.9x|S&P 22.1x
Forward P/E
22.0x
Expensive
EV / EBITDA
7.0x
Fair
Sector 7.2x|S&P 14.9x
PEG
0.46
Growth unpriced
Sector 0.53|S&P 0.84
Fair value (reverse DCF)
1.57 GBP
Fairly priced
P/E vs its own 5-year history
among the 23% highest valuations
Pricier than usual
Market cap
210M GBP
Financial strength
10.0/10Cash covers 27746.4% of the debt, net debt/EBITDA -6.3x.
Net debt / EBITDA
-6.3x
Net cash
Gearing (net debt / equity)
-63.10%
Net cash
Cash
95.7M GBP
Cash / market cap
45.54%
Very solid
Cash / total debt
27746.36%
Net cash
Net debt
-95.3M GBP
Equity
151M GBP
Closed daily candles, 2 years
Last close on November 20, 2026: 1.63 GBP
- MM201.71
- MM501.77
- MM2001.66
- RSI 1432.5
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
-0.11%
200-day average slope, 3 months
+0.27%
50-day average slope, 1 month
-1.00%
Price structure
higher-low
Bullish RSI divergence
No
20-day volatility
2.38 % per day
Volatility change
+93.71%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2027 | 0.07 (1) | 0.10 (2) | 58 (2) | 16 (2) | 10 (1) |
Amounts in millions of GBP, EPS in GBP per share. In brackets, the number of analysts. Consensus as of November 2, 2026.
Same sub-industry: 823 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 3687 | 6.3 | 6.7 | 286M USD | 23.2x | 18.4 % | 7.5 % | 21.5 % | -2.2x | — | -14.8 % | ||
| 2 | SASKEN | 5.6 | 5.2 | 300M USD | 33.4x | 6.8 % | 25.6 % | 9.7 % | -1.7x | — | 32.2 % | ||
| 3 | EGHT | 5.5 | 5.6 | 286M USD | 38.4x | 1.0 % | 4.3 % | 1.7 % | 5.4x | 18.4 % | 3.2 % | ||
| 4 | ADVT | 5.5 | 5.6 | 275M USD | 24.1x | 17.0 % | 13.2 % | 6.5 % | -6.3x | 5.4 % | -9.7 % | ||
| 5 | ROUTE | 5.3 | 6.3 | 281M USD | 7.5x | 7.6 % | 5.4 % | 12.8 % | -2.5x | — | -39.0 % | ||
| 6 | SMCRT | 5.2 | 5.2 | 298M USD | 32.0x | 16.9 % | 10.9 % | 10.1 % | -0.6x | 5.6 % | 24.2 % | ||
| 7 | API | 3.5 | 3.3 | 296M USD | 26.5x | 7.1 % | 19.2 % | 1.7 % | 134.0x | -3.3 % | -8.8 % | ||
| 8 | 9669 | 3.4 | 3.5 | 279M USD | Not meaningful (loss) | -2.1 % | 19.0 % | -2.1 % | 104.0x | 6.5 % | -56.4 % | ||
| 9 | 301159 | 2.6 | 2.9 | 286M USD | 55.0x | 8.6 % | 12.8 % | 5.8 % | -21.4x | 0.3 % | -31.9 % |
